Correspondence on: ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern‘

The mosaic of autoimmunity – Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens

“…Hocevar and colleagues contrasted systemic vasculitis diagnosis before and during the pandemic of COVID-19 at secondary/tertiary medical centers. The authors found similar frequencies in most vasculitis except ANCA-associated vasculitis which was diagnosed 3 folds more during the pandemic when compared to the frequency of diagnosis prior to that [ 149 ]. Similarly, Irure-Ventura retrospectively compared ANCA vasculitis cases in 2019 to 2021 at University Hospital Marqués de Valdecilla.…”

Response to: ‘Correspondence on ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’’ by Hocevar et al

“…No significant differences were found in incidence rates or indications for deferrals; that is, symptoms were experienced for a longer length of time before a diagnosis was made or a more severe presentation occurred. 2 As the COVID-19 pandemic remains ongoing, six patients with AAV treated at our centre contracted COVID-19; clinical details are summarised in table 1. One patient (patient 2) on maintenance rituximab required intensive care unit treatment, while another with a recent disease relapse (patient 1) was hospitalised.…”